Form 4 for EXEL EXELIXIS, INC.
Accepted 2024-11-19 00:00:00 ET · period of report 2024-11-15 · accession 0000939767-24-000158 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | 2024-11-15 | EXEL | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | F - Tax | $35.05 | -27.2K | 294.9K | -8% | -$954.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-15 | F | D | 27,224 | $35.05 | 294,897 | D | — | — | (F1) Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded August 24, 2023. (F2) Includes 262,121 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs. Each RSU is the economic equivalent of one share of Common Stock. |